Bridge Pharma Raises $35 Million

Bridge Pharmaceuticals Inc., a provider of preclinical contract research to drug manufacturers, has raised $35 million in Series B funding. Granite Global Ventures was joined by return backers, but Bridge declined to specify which ones. Bridge